Aptevo Therapeutics Inc. (APVO)

CIK 1671584 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Aptevo Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Sep 3, 2026424B40001193125-26-381149
Sep 3, 20268-K0001193125-26-381098
Sep 2, 2026EFFECT9999999995-26-002871
Aug 31, 2026DEF 14A0001193125-26-376763
Aug 26, 2026D0001193125-26-368286
Aug 21, 2026PRE 14A0001193125-26-361119
Aug 21, 2026S-10001193125-26-361103
Aug 21, 20268-K0001193125-26-361079
Aug 14, 202610-Q0001193125-26-350559
Aug 14, 2026SCHEDULE 13G/A0001649553-26-000098
Aug 14, 20268-K0001193125-26-350537
Aug 13, 20268-K0001193125-26-349380
Aug 10, 202640001193125-26-343073
Aug 10, 202640001193125-26-343072
Aug 10, 202640001193125-26-343069
Aug 10, 202640001193125-26-343076
Aug 10, 202640001193125-26-343077
Aug 10, 202640001193125-26-343070
Aug 10, 202640001193125-26-343065
Aug 10, 202640001193125-26-343067
Aug 10, 202640001193125-26-343080
Aug 10, 202640001193125-26-343079
Jul 31, 2026ARS0001193125-26-328465
Jul 31, 2026DEF 14A0001193125-26-328604
Jul 27, 20268-K0001193125-26-318056